Tyrosine-kinase inhibitor combined with iodine-125 seed brachytherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: a propensity-matched study

PURPOSE: To investigate the efficacy and safety of tyrosine-kinase inhibitor (TKI) combined with iodine-125 seed brachytherapy (TKI-I) versus TKI alone for patients with hepatocellular carcinoma (HCC) refractory to transarterial chemoembolization (TACE). METHODS: Data of patients with TACE-refractor...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yongjian, Wu, Jingqiang, Liang, Licong, Zhu, Kangshun, Zhou, Jingwen, Lin, Liteng, Chen, Ye, Cao, Bihui, He, Mingji, Lian, Hui, Huang, Wensou, Cai, Mingyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518921/
https://www.ncbi.nlm.nih.gov/pubmed/37749616
http://dx.doi.org/10.1186/s40644-023-00604-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518921/
https://www.ncbi.nlm.nih.gov/pubmed/37749616
http://dx.doi.org/10.1186/s40644-023-00604-4

Ejemplares similares